Invesco Health Care R (GTHRX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
40.36
+0.33 (0.82%)
Jun 29, 2026, 4:00 PM EST
Fund Assets1.14B
Expense Ratio1.32%
Min. Investment$1,000
Turnover59.00%
Dividend (ttm)2.20
Dividend Yield5.46%
Dividend Growthn/a
Payout Frequencyn/a
Ex-Dividend DateDec 18, 2025
Previous Close40.03
YTD Returnn/a
1-Year Returnn/a
5-Year Returnn/a
52-Week Low35.12
52-Week High40.36
Beta (5Y)n/a
Holdings81
Inception Daten/a

About GTHRX

The Invesco Health Care Fund is an actively managed mutual fund specializing in investments within the global health care sector. Its primary objective is to achieve long-term capital growth by allocating at least 80% of its assets to equity securities, including common stocks and depository receipts, of health care companies worldwide. The fund covers a broad array of sub-sectors, such as health care equipment, biotechnology, pharmaceuticals, distributors, services, and facilities, with a significant portion of its holdings concentrated in leading names like Boston Scientific, Eli Lilly, Stryker, AbbVie, and Cencora. The fund employs a research-intensive, bottom-up approach to select industry-leading companies that are expected to demonstrate above-average growth rates and operational strength. Risk management is an integral component of its investment strategy, reflecting the health care sector's susceptibility to regulatory changes, reimbursement pressures, pricing dynamics, and innovations. With a diversified portfolio extending across the United States and select countries in Europe, the fund plays a prominent role for investors seeking targeted exposure to health care innovation and sectoral growth within the broader equity market.

Fund Family Invesco
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol GTHRX
Share Class Class R

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
GGHYXClass Y0.82%
GTHIXInvestor Class1.07%
GGHCXClass A1.07%
GTHCXClass C1.82%

Top 10 Holdings

44.20% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY9.65%
Johnson & JohnsonJNJ5.85%
AstraZeneca PLCAZN4.18%
Gilead Sciences, Inc.GILD3.90%
UnitedHealth Group IncorporatedUNH3.79%
argenx SEARGX3.66%
AbbVie Inc.ABBV3.62%
McKesson CorporationMCK3.43%
Cencora, Inc.COR3.12%
Invesco Private Prime Fundn/a3.01%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 18, 2025$2.2025Dec 18, 2025
Full Dividend History